• Clinically proven
    clinically_proven_logo

    The efficacy and tolerance of Diosmectite on acute and chronic diarrhoea has been clinically proven in many studies.

    Diosmectite has been used successfully and safely for generations by doctors and patients around the world

     

    • Treats acute and chronic diarrhoea.
    • Adsorbs toxins and contaminants such as e-coli or rotavirus.
    • Reduces inflammation.
    • Protects the intestinal mucosa.
    • Shortens diarrhoea duration and normalises transit.
    • High tolerance, even with very young children.

    Anti-diarrheal effects of diosmectite in the treatment of acute diarrhoea in children. A Review, Christophe Dupont and Bernard Vernisse, Pediatr. Drugs 2009, 11 (2) 89-99

    Treatment of acute diarrhoea in adults with dioctahedral smectite (Smecta): a prospective randomised study, KH Cheung and WL Yuen, Hong Kong Journal of Medicine vol13(2) 2006, 85-89

    Management of Lithuanian Children’s Acute Diarrhoea With Gastrolit Solution And Dioctahedral Smectite, Irena Narkevicuite And Odilija Rudzeviciene And Giedra Levinine And Kristina Mociskiene And Rimantas Eidukevicius, 419-424, 2002

    Oral Diosmectite reduces stool output and diarrhoea duration in children with acute watery diarrhoea, Christophe Dupont, Clinical Gastroenterology and Hepatology, 2009, 456-462

    Role of Antidiarrheal drugs as adjunctive therapies for Acute Diarrhoea in Children, Christopher Faure, 1-14, and 2013

    Smectite in Acute Diarrhoea in Children: A Double Blind Placebo-Controlled Clinical Trial, Ahmed A. Madkour, Journal of Pediatric Gastroentology and Nutrition, 1993, 176-181

    European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases Evidence-Based Guidelines for the Management of Acute Gastroenteritis in Children in Europe: Update 2014. Guarino, Alfredo (Coordinator), Journal of Pediatric Gastroenterology & Nutrition: July 2014 – Volume 59 – Issue 1 – p 132-152

    Apical effect of diosmectite on damage to the intestinal baffler induced by basal tumour necrosis factor-cx, L Mahraoui, Gut 1997; 40: 339-343